Changes in body composition and metabolic profile during interleukin 6 inhibition in rheumatoid arthritis

BACKGROUND: Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by increased mortality associated with cardiometabolic disorders including dyslipidaemia, insulin resistance, and cachectic obesity. Tumour necrosis factor inhibitors and interleukin 6 receptor blocker licensed for...

Full description

Saved in:
Bibliographic Details
Published in:J Cachexia Sarcopenia Muscle
Main Authors: Tournadre, Anne, Pereira, Bruno, Dutheil, Fréderic, Giraud, Charlotte, Courteix, Daniel, Sapin, Vincent, Frayssac, Thomas, Mathieu, Sylvain, Malochet‐Guinamand, Sandrine, Soubrier, Martin
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2017
Subjects:
Original Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5566648/
https://ncbi.nlm.nih.gov/pubmed/28316139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcsm.12189
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items